IBDEI0MQ ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10214,2)
 ;;=^5002665
 ;;^UTILITY(U,$J,358.3,10215,0)
 ;;=E11.9^^39^431^35
 ;;^UTILITY(U,$J,358.3,10215,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10215,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,10215,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,10215,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,10216,0)
 ;;=E11.29^^39^431^27
 ;;^UTILITY(U,$J,358.3,10216,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10216,1,3,0)
 ;;=3^DM Type 2 w/ Oth Diab Kidney Compl
 ;;^UTILITY(U,$J,358.3,10216,1,4,0)
 ;;=4^E11.29
 ;;^UTILITY(U,$J,358.3,10216,2)
 ;;=^5002631
 ;;^UTILITY(U,$J,358.3,10217,0)
 ;;=E11.311^^39^431^14
 ;;^UTILITY(U,$J,358.3,10217,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10217,1,3,0)
 ;;=3^DM Type 2 w/ Diab Rtnop w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,10217,1,4,0)
 ;;=4^E11.311
 ;;^UTILITY(U,$J,358.3,10217,2)
 ;;=E11.319^5002632
 ;;^UTILITY(U,$J,358.3,10218,0)
 ;;=E11.319^^39^431^15
 ;;^UTILITY(U,$J,358.3,10218,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10218,1,3,0)
 ;;=3^DM Type 2 w/ Diab Rtnop w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,10218,1,4,0)
 ;;=4^E11.319
 ;;^UTILITY(U,$J,358.3,10218,2)
 ;;=^5002633
 ;;^UTILITY(U,$J,358.3,10219,0)
 ;;=E11.3211^^39^431^22
 ;;^UTILITY(U,$J,358.3,10219,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10219,1,3,0)
 ;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Rt Eye
 ;;^UTILITY(U,$J,358.3,10219,1,4,0)
 ;;=4^E11.3211
 ;;^UTILITY(U,$J,358.3,10219,2)
 ;;=^5138331
 ;;^UTILITY(U,$J,358.3,10220,0)
 ;;=E11.3212^^39^431^23
 ;;^UTILITY(U,$J,358.3,10220,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10220,1,3,0)
 ;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Lt Eye
 ;;^UTILITY(U,$J,358.3,10220,1,4,0)
 ;;=4^E11.3212
 ;;^UTILITY(U,$J,358.3,10220,2)
 ;;=^5138332
 ;;^UTILITY(U,$J,358.3,10221,0)
 ;;=E11.3213^^39^431^24
 ;;^UTILITY(U,$J,358.3,10221,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10221,1,3,0)
 ;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Bilat
 ;;^UTILITY(U,$J,358.3,10221,1,4,0)
 ;;=4^E11.3213
 ;;^UTILITY(U,$J,358.3,10221,2)
 ;;=^5138333
 ;;^UTILITY(U,$J,358.3,10222,0)
 ;;=E11.40^^39^431^10
 ;;^UTILITY(U,$J,358.3,10222,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10222,1,3,0)
 ;;=3^DM Type 2 w/ Diab Neuropathy,Unspec
 ;;^UTILITY(U,$J,358.3,10222,1,4,0)
 ;;=4^E11.40
 ;;^UTILITY(U,$J,358.3,10222,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,10223,0)
 ;;=E11.51^^39^431^12
 ;;^UTILITY(U,$J,358.3,10223,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10223,1,3,0)
 ;;=3^DM Type 2 w/ Diab Periph Angiopathy w/o Gangrene
 ;;^UTILITY(U,$J,358.3,10223,1,4,0)
 ;;=4^E11.51
 ;;^UTILITY(U,$J,358.3,10223,2)
 ;;=^5002650
 ;;^UTILITY(U,$J,358.3,10224,0)
 ;;=E11.52^^39^431^11
 ;;^UTILITY(U,$J,358.3,10224,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10224,1,3,0)
 ;;=3^DM Type 2 w/ Diab Periph Angiopathy w/ Gangrene
 ;;^UTILITY(U,$J,358.3,10224,1,4,0)
 ;;=4^E11.52
 ;;^UTILITY(U,$J,358.3,10224,2)
 ;;=^5002651
 ;;^UTILITY(U,$J,358.3,10225,0)
 ;;=E11.620^^39^431^5
 ;;^UTILITY(U,$J,358.3,10225,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10225,1,3,0)
 ;;=3^DM Type 2 w/ Diab Dermatitis
 ;;^UTILITY(U,$J,358.3,10225,1,4,0)
 ;;=4^E11.620
 ;;^UTILITY(U,$J,358.3,10225,2)
 ;;=^5002655
 ;;^UTILITY(U,$J,358.3,10226,0)
 ;;=E11.36^^39^431^4
 ;;^UTILITY(U,$J,358.3,10226,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10226,1,3,0)
 ;;=3^DM Type 2 w/ Diab Cataract
 ;;^UTILITY(U,$J,358.3,10226,1,4,0)
 ;;=4^E11.36
